Anti-diabetic treatment associated with reduced risk of developing blood cancer
People who use metformin are less likely to develop a myeloproliferative neoplasm (MPN) over time, indicating that the treatment may help prevent the development of certain types of cancers, according to a study published in Blood Advances. Metformin is a therapy used to treat high blood sugar in people with type 2 diabetes that increases … Read more
